Table 3. The rates of reactivation of hepatitis B and related events in patients (n = 134) with and without antiviral prophylaxis before prescribing chemotherapy.

	With prophylaxis	Without prophylaxis	P value
	(n = 61)	(n = 73)
Reactivation of hepatitis B	1 (1.6%)	11 (15.1%)	< 0.01
Hepatic decompensation	0 (0%)	4 (5.5%)	0.13
Hepatitis B related delay of chemotherapy	1 (1.6%)	11 (15.1%)	< 0.01
Hepatic failure and mortality	0 (0%)	2 (2.7%)	0.50